News

Pfizer, Manipal Hospitals & others join hands to accelerate health tech startups in India

health-tech

A group of healthcare entities, including Manipal Hospitals and health-techNarayana Health, have got together with an investor to provide up to Rs 10 crore ($1.6 million) in grants and investments to early-stage startups that seek to enhance access to affordable technology-driven healthcare products and services for low-income masses in India.

Apart from the two hospitals, the programme known as StartHealth is backed by investor Unitus Seed Fund, PATH, an international non-profit organisation, a and pharmaceutical major Pfizer. “Many of the 150 healthcare entrepreneurs we’ve met over two years weren’t ready yet for an investment from us. With StartHealth, we can engage and invest even earlier in their development. There is a massive supply-demand gap for healthcare services in India. If you can create access and affordability, the demand is massive.
Technology can be a game-changer to enable access and affordability,” said Dave Richards, managing partner of Unitus Seed Fund.
The partners expect to select up to five startups in 2015. They will get up to Rs 50 lakh ($85,000) of nondilutive capital to fund immediate pre-seed business progress for six to 12 months and hands-on support from PATH, Manipal Hospitals and Narayana Health’s staff.
They also get access to expert networks of PfizerBSE -1.11 %, PATH, Manipal Hospitals, Narayana Health and Unitus in India and globally and facilities of Manipal Hospitals and Narayana Health for pilots and market testing.

Areas of interest for healthcare innovation for StartHealth partners are low-cost diagnostic and monitoring devices connecting doctors and patients, healthcare cloud IT solutions and innovations for use in labs or clinical settings to improve the quality of care at lower levels of healthcare system, such as primary care clinics.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon1Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top